2 studies found for:    XP21279
Show Display Options
Rank Status Study
1 Completed A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects
Condition: Parkinson's Disease
Interventions: Drug: XP21279 and carbidopa (experimental);   Drug: Sinemet (comparator);   Drug: Placebo for XP21279 and carbidopa;   Drug: Placebo for Sinemet
2 Completed An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease Subjects
Condition: Parkinson's Disease
Interventions: Drug: XP21279;   Drug: Sinemet®;   Drug: Lodosyn®

Indicates status has not been verified in more than two years